Dosidal · Poland
Prometax
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:presentation:90409 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | rpl-pack-id: 90409 eu-number: EU/1/98/092/030 |
| Source authority | URPL |
| Read date | 2026-11-15T02:02:49Z |
| controlled status | availability_category: Rpz definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf narcotic_or_psychotropic: False state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: N06DA03 deleted: False eu_pack_number: EU/1/98/092/030 form: System transdermalny holder: Novartis Europharm Limited medicine: Prometax pack_units: liczbaOpakowan: 90 rodzajOpakowania: sasz. procedure: CEN routes: na skórę strength: 13,3 mg/24 h substances: substance: Rivastigminum state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| pack product code | state: unknown |
| prescription class | availability_category: Rpz definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf prescription: True state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53mhd1Tfd1NvZjZA4kVJiDQpYp3kCATzHHPW9l2EK1E6Zu3ZXw451E-xYsCqrxYlYr415k3qvO8w8Z2E-VHiVG7AVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/pl:presentation:90409 · Related records in other markets · Dosidal